Medicare Enrolled

Dr. Nectar Aintablian, M.D.

Pediatric Infectious Diseases Physician · Tallahassee, FL
1881 PROFESSIONAL PARK CIR STE 80, Tallahassee, FL 32308
8504025454
Registered in NPPES since 2006
NPI: 1710937966 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aintablian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aintablian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aintablian

Dr. Nectar Aintablian is a pediatric infectious diseases physician in Tallahassee, FL, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Aintablian received a total of $580 from 16 pharmaceutical and/or device companies across 34 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aintablian is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $580 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 72425 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$580
Total received (2018-2024)
Avg $83/year across 7 years
Top 41% in FL for pediatric infectious diseases physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
16
Companies
34
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$28
2023
$94
2022
$55
2021
$112
2020
$45
2019
$133
2018
$114

Payments by company (2024)

Philips North America LLC
$15
GlaxoSmithKline, LLC.
$13
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$136
SANOFI PASTEUR INC.
$69
Neos Therapeutics, LP
$67
Corium, LLC
$40
Tris Pharma Inc
$34
Corium, Inc.
$33
GlaxoSmithKline, LLC.
$30
Takeda Pharmaceuticals U.S.A., Inc.
$30
NESTLE HEALTHCARE NUTRITION INC.
$22
Ironshore Pharmaceuticals Inc.
$22
Phadia US Inc.
$22
AstraZeneca Pharmaceuticals LP
$19
Philips North America LLC
$15
Merck Sharp & Dohme Corporation
$14
Shire North American Group Inc
$14
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 46.9% of all-time payments
Associated products mentioned in payments ›
(CK7) Extended Holter · AZSTARYS · Adzenys XR-ODT · Azstarys · BEXSERO · Cotempla XR-ODT · EUCRISA · FLUMIST QUADRIVALENT · FLUZONE QUADRIVALENT · ImmunoCAP · JORNAY PM · NO PRODUCT DISCUSSED · PREVNAR - 13 · PREVNAR 13 · QVAR · Quillichew ER · VAXELIS · VYVANSE · Vyvanse
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pediatric infectious diseases physician in Tallahassee?
Compare pediatric infectious diseases physicians in the Tallahassee area by procedure volume, costs, and industry payment transparency.
Browse pediatric infectious diseases physicians nearby

Geographic Context

Pediatric infectious diseases physicians in nearby ZIP areas
1
County median income
$65,074
Nearest hospital to ZIP centroid (approximate)
TALLAHASSEE MEMORIAL HEALTHCARE
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Aintablian is a pediatric infectious diseases physician, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Aintablian receive payments from pharmaceutical companies?
Yes. Dr. Aintablian received a total of $580 from 16 companies across 34 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Aintablian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →